Evidence map›Paper›PMID 25530693›Full record

ArticleProgress in pediatric cardiology2014

Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine.

Daniel Bernstein, Paul Burridge

Abstract read
In one paragraph

Article in Progress in pediatric cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel BernsteinDepartments of Pediatrics and Medicine, Stanford Cardiovascular Institute, Stanford University.
Paul BurridgeDepartments of Pediatrics and Medicine, Stanford Cardiovascular Institute, Stanford University.

Funding

hiPSC-Cardiomyocytes to Screen Variants Predictive of Doxorubicin CardiotoxicityR33HL123655 · NHLBI · STANFORD UNIVERSITY · PI BERNSTEIN, DANIEL · 2016 to 2018
$1.4M
Modeling the role of the genome in chemotherapy induced cardiotoxicity using iPSCR00HL121177 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BURRIDGE, PAUL W. · 2015 to 2017
$743k
iPSC-Derived Cardiomyocytes in Left Ventricular Non-Compaction CardiomyopathyK18HL117083 · NHLBI · STANFORD UNIVERSITY · PI BERNSTEIN, DANIEL · 2013 to 2014
$487k
hiPSC-Cardiomyocytes to Screen Variants Predictive of Doxorubicin CardiotoxicityR21HL123655 · NHLBI · STANFORD UNIVERSITY · PI BERNSTEIN, DANIEL · 2014 to 2015
$434k
Modeling the role of the genome in chemotherapy induced cardiotoxicity using iPSCK99HL121177 · NHLBI · STANFORD UNIVERSITY · PI BURRIDGE, PAUL W. · 2014 to 2014
$89k
NHLBI NIH HHS K18 HL117083NHLBI NIH HHS K99 HL121177NHLBI NIH HHS R00 HL121177NHLBI NIH HHS R21 HL123655NHLBI NIH HHS R33 HL123655
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID25530693
PMCPMC4267060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.